Ikarian Capital, LLC - Q3 2016 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q3 2016
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
XENON PHARMACEUTICALS INC15Q2 20231.5%
OCULAR THERAPEUTIX INC15Q3 20231.4%
SAREPTA THERAPEUTICS INC14Q3 20236.4%
X4 PHARMACEUTICALS INC - PIPE14Q2 20231.4%
PROTARA THERAPEUTICS INC14Q3 20231.2%
SPDR SER TR13Q3 20239.0%
VAXCYTE INC13Q3 20232.9%
TRACON PHARMACEUTICALS INC13Q3 20231.4%
MILESTONE PHARMACEUTICALS IN13Q3 20231.7%
BELLUS HEALTH INC NEW13Q1 20231.8%

View Ikarian Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Ikarian Capital, LLC Q3 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Milestone Pharmaceuticals Inc.February 14, 2023460,4161.3%
X4 Pharmaceuticals, IncFebruary 14, 2023349,1330.3%
aTYR PHARMA INCFebruary 14, 202235,0480.1%
Cyclacel Pharmaceuticals, Inc.February 14, 202299,4221.0%
KalVista Pharmaceuticals, Inc.February 14, 202236,5760.2%
Lyra Therapeutics, Inc.February 14, 2022394,5363.0%
Odonate Therapeutics, Inc.February 14, 20221,340,6313.5%
Protara Therapeutics, Inc.February 14, 2022279,2562.5%
Science 37 Holdings, Inc.Sold outFebruary 14, 202200.0%
scPharmaceuticals Inc.February 14, 2022901,3623.3%

View Ikarian Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-04-05
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14

View Ikarian Capital, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Ikarian Capital, LLC's holdings

CSVXLS